Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Articles by M.K. Anwer
Total Records ( 2 ) for M.K. Anwer
  F. Imam , M.K. Anwer , M. Iqbal , S. Alam , K.U. Khayyam and M. Sharma
  Tuberculosis, or TB, is one of the most ancient infectious bacterial disease caused by Mycobacterium tuberculosis. On the basis of site of tuberculosis it is mainly divided in to two categories: pulmonary and extra-pulmonary which is further divided into 5 and 7 different category, respectively. The TB is a highly contagious disease that is usually transmitted by coughing and sneezing. It is mainly diagnosed by detecting the presence of Mycobacterium tuberculosis bacteria, abnormal chest x-ray and surgical biopsy in the patient. In 1998, World Health Organization has declared this disease a global emergency and established a new strategy for treating patients, called Directly Observed Treatment, Short-course (DOTS). India is the highest TB burden country accounting for one fifth of the global incidence. There has been significant change in management of tuberculosis never since pre-chemotherapeutic era to the present day RNTCP protocol based on specific disease categories. Its initial management in an organized way was started in late 1930 when the main line of treatment was good food, open air and dry climate. Effective drugs against TB began available around the time India gained Independence and District Tuberculosis Programme (DTP) was started to reduce the TB problem across the country. But major problem raised was that of keeping the patients on continuous treatment as only 66% of the patients were taking drugs regularly. In seventies, availability of two highly effective drugs-rifampicin and pyrazimamide enabled to cut down the duration of treatment and Short Course Chemotherapy (SCC) policy was implemented. Inspite of the introduction of SCC, a high rate of defaulters and the disturbing trends of low compliance in SCC districts were reported. In 1992, the Government of India designed the Revised National Tuberculosis Control Programme based on DOTS strategy. Phase II of the RNTCP started from October 2005, which is a step towards achieving the TB-related targets of the Millennium Development Goals. By March 2006, the programme was implemented nationwide in 633 districts, covering 1114 million (100%) population. In 2008, 1.51 million patients have already been placed on treatment and NSP treatment success rate was 86%.
  M.K. Anwer , S. Jamil , M. Ahmad , M.N. Ansari and T.H. Khan
  This study was performed on the possibility of novel complexing agent/bioavailability enhancer in the form of complexation of aspirin with fulvic acid. Solid complexes of aspirin-fulvic acid prepared by solvent evaporation, freeze drying and spray drying methods. These complexes were characterized by using differential scanning calorimetry, fourier transform infrared spectroscopy, powder X-ray diffractometry and scanning electron microscopy. In addition, the influences of the fulvic acid on the dissolution, permeation, stability and pharmacodynamics profile of the complexes were studied. In vitro dissolution studies confirmed the successful complexation by the spray drying method in a molar ratio of 1: 1. The prepared optimized complex showed an improvement in stability and permeability (8 times as compared to pure drug). A significant (p<0.05) anti-inflammatory action of the treatment of optimized spray dried (1:1) aspirin complex with fulvic acid was evidenced by inhibition of rat paw edema and anti-ulcerogenic action was measured by lowest score of ulcer index (0.480.08) with significant reduction in ulceration as compared to pure drug. Fulvic acid appears to be beneficial to overcome the problem of stability and bioavailability of aspirin. A highly significant anti-inflammatory and anti-ulcerogenic action was observed by the treatment of optimized complex. Technology has been developed which can be used for improvement formulation of aspirin.
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility